Intrinsiqs

Is Neogen Corporation overvalued?

Neogen Corporation (NEOG) looks overvalued — trading about 27% above its fair value.

Overvalued
Current price $13.72 Fair value $10.06
Price
$13.72
Fair value
$10.06
Current P/E
49.0
Normal P/E
35.9
Market cap
$2.99B
Dividend yield
0.0%
Return on equity
-0.4%
Sector
Healthcare

See the full interactive analysis →

Fair value compares NEOG's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.MRK Merck & Co., Inc.RHHBY Roche Holding AGUNH UnitedHealth Group Incorporated